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1. In~odu~tion 
There is much in vitro evidence that skeletal muscle 
glycogen synthase is regulated through phosphoryla- 
tion-dephosphorylation mechanisms [l-3]. The 
number of phospho~lation sites as indicated by the 
amount of phosphate per mole of subunit has been 
reported to be between l-6 [4- 131. However, all 
these studies have correlated the phosphate content 
and the activity of the purified enzyme after in vitro 
modification by protein kinases, and there have been 
only two brief reports on the phospho~lation state 
of the enzyme in vivo j3 ,141. 
Using the rat hindlimb perfusion technique we have 
presented kinetic evidence that glycogen synthase is 
substantially phosphorylated in control skeletal muscle 
and that epinephrine causes further phosphorylation 
[ 151. Here, we have measured the chemical phosphate 
of the enzyme purified from control and hormone- 
treated muscle and have found a good correlation 
between the phosphorylation state of the enzyme and 
its activity. 
2. Methods 
The method used for hindlimb perfusion has been 
described [lo]. Hindlimbs from fed rats (180-220 g 
Abbreviations: con A, conca~valin A; G-6-P, gIucose~-phos- 
phate; SDS, sodium dodecyl sulfate;Mr relative molecular mass 
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body wt) were perfused with Krebs-~enseleit bicar- 
bonate buffer containing 33% aged human erythro- 
cytes, 4% bovine serum albumin and 10 mM D-glucose. 
The muscles were perfused for 20 min without hor- 
mones and then infused with either saline or epineph- 
rine(lO-7 M)for20min.At theendof the treatment 
period, the muscles were quickly extracted and homog- 
enized in icecold buffer comprising 5 mM EDTA, 
100 mM NaF , 1 mM DTT and trasylol(42.5 units/l) 
at pH 7 .O. Homogenates of muscles (-80 g) from 
8 perfusions were used for each enzyme preparation. 
Purification of glycogen synthase was similar to 
that in [ 171 up to the second glycogen pellet. The 
resuspended pellet was then put onto a con A- 
Sepharose column as in [ 181. After amylase digestion 
the enzyme was finally applied to a DEAE-Sepharose 
column and eluted with a linear NaCl gradient. 
Throughout the purification, glycogen synthase 
was assayed according to 1191 and the K, for G-6-P 
was obtained from plots of the data [ 151. Protein was 
determined by the method in [20] and alkali-labile 
phosphate by the malachite-green technique [21]. 
SDS-polyacrylamide gel electrophoresis (7 .S%) was 
done as in [22] in amediol-sulfate buffer. Regular 
polyacrylamide disc-gel electrophoresis was done as in 
[23] with the addition of 1 mM G-6-P in the upper 
reservoir buffer [ 171. Protein bands in gels were 
detected by staining with Coomassie blue [24], and 
the presence of glycogen synthase was confirmed by 
the iodine activity stain f2.51 and also by measuring 
the enzyme activity eluted from sliced gel. 
3. Results 
Table 1 illustrates the puri~cation scheme for gly- 
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Table 1 
Muscle glycogen synthase purification 
Procedure 
1. Extract 
2. Acidification 
3. 1 st Glycogen 
pellet 
4.2nd Glycogen 
pellet 
5. Con A-Sepharose 
6. DEAE-Sepharose 
Total 
units 
121 
58 
46 
46 0.35 36% 12 
22 7.20 18% 240 
5 40.0 4% 1330 
Units/mp 
protein 
0.03 
0.22 
0.27 
Yield Purifi- 
(54) cation 
100% 1 
48% 7 
38% 9 
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Fig.1. Con A-Sepharose profile: The column was washed 
overnight with buffer containing 50 mM Tris, 50 mM NaF, 
1 mM MgCl,, 1 mM CaCl,, 1 mM MnCl,, 0.5 M NaC1, 1 mM 
DTT at pH 7.5. Glycogen synthase was then eluted with 
50 mM Tris buffer containing 50 mM NaF, 1 mM DTT and 
200 mM glucose at pH 7.5. The column dimensions were 
5 X 10 cm and the flow rate was 70 ml/h. 
Fig.2. DEAE-Sepharose profile: The amylase-treated enzyme 
was applied to a DEAE-Sepharose column and eluted by a 
salt gradient using a 50 mM Tris buffer containing 5 mM 
EDTA, 50 mM NaF, 1 mM DTT at pH 7.5 The column 
dimensions were 2.5 X 5 cm and the flow rate was 30 ml/h. 
A B 
Fig.3. SDSpolyacrylamide gel electrophoresis (7.5%) of 
purified glycogen synthase: Elcctrophoresis was performed at 
2 mA/tube using amediol-sulfate as the reservoir buffer. 
(A) Positions of subunits of marker proteins, i.e., phosphoryl- 
ase (94 000 Mr), bovine serum albumin (67 000 M,), oval- 
bumin (43 000 M,) and carbonic anhydrase (30 000 M,); 
(B) enzyme preparation. 
cogen synthase. The enzyme was purified 1300-fold 
giving a final spec. act. of 40 U/mg protein with a 
total recovery of 4% of the initial activity. Con A- 
Sepharose chromatography was a major step in the 
purification procedure and resulted in a 20-fold puri- 
fication. While the bulk of the protein appeared in 
the void volume (fig.l), glycogen synthase remained 
on the column and was eluted with 200 mM glucose. 
Table 2 
Glycogen synthase activity ratio and K, for G-6-P during 
purification from control and cpinephrine-perfused muscle 
Procedure Control Epinephrine 
Activity 
ratio 
1. Extract 0.14 
2. Acidification 0.16 
3. 1st Glycogen 
pellet 0.16 
4.2nd Glycogen 
pellet 0.18 
5. Con A-Sepharose - 
6. DEALSepharose 0.16 
G-6-P Activity G-6-P 
K, (mM) ratio K, (mM) 
0.15 0.04 1.20 
_ 0.04 - 
_ 0.04 
_ 0.05 - 
_ _ _ 
0.13 0.04 0.95 
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Table 3 
Phosphorylation state of glycogen synthase 
Treatment mol Phosphate/ 
85 000 g protein 
Control 
Epinephrine 
3.1 
4.9 
Another 5 -fold purification was achieved by DEAE- 
Sepharose chromatography (fig.2), where the enzyme 
was eluted by a salt gradient (0.15-0.3 M NaCl) as a 
single symmetrical protein peak corresponding to the 
activity peak. SDS-polyacrylamide gel electrophoresis 
of the material in this peak showed a major 85 OOOM, 
band with an accompanying 40 000 Mr band (fig.3). 
Scans of gels showed that the minor band correspond- 
ed to 25% of total protein. This pattern is similar to 
that reported for the rabbit muscle enzyme [ 171. Gel 
electrophoresis without detergent showed a single 
protein band corresponding to the glycogen synthase 
activity determined by iodine stain and activity assayed 
from sliced gel (not shown). 
The kinetics of glycogen synthase isolated from 
control or epinephrine-treated muscle, as assessed by 
the activity ratio (-G-6P/+G-6-P) and K, for G-6-P, 
changed minimally or not at all throughout the purifi- 
cation procedure (table 2). The activity ratio was 0.14 
in the control group and decreased to 0.04 after 
epinphrine treatment. The basal K, for G-6-P was 
0.15 mM andwas increased by the hormone to 1.2 mM. 
The measured chemical phosphate of the purified 
glycogen synthase is shown in table 3. The basal phos- 
phate content in the control group was 3.1 mol/ 
85 000 g protein. Epinephrine treatment resulted in the 
incorporation of almost 2 mol phosphate in addition. 
4. Discussion 
The usual procedure for purifying skeletal muscle 
glycogen synthase was modified by including con A- 
Sepharose chromatography as a major step. This 
approach gave us a 1300-fold purification of an enzyme 
approaching homogeneity (fig.3) with spec. act. 
40 U/mg. More importantly, there was little or no 
change in the kinetics of the enzyme during the puri- 
fication (table 2), suggesting that its phosphorylation 
state was not altered. 
Phosphorylation of skeletal muscle glycogen syn- 
thase by cAMPdependent protein kinase in vitro 
results in decreased enzyme activity [5-8 ,12 ,131. 
Epinephrine treatment ofintact skeletal muscle result- 
ed in similar kinetic changes [ 151; the kinetic proper- 
ties of the enzyme in muscle perfused without 
hormones were consistent with a high degree of phos- 
phorylation [ 151. These data support that conclusion 
about the phosphorylation stateof the control enzyme. 
Consistent with the current concept that epinephrine 
causes its metabolic effects in skeletal muscle via CAMP 
and cAMPdependent protein kinase, the hormone 
caused a further increase in phosphate content. These 
findings in an isolated, perfused rat muscle preparation 
support the conclusions in [26]; i.e., that the enzyme 
isolated from skeletal muscle of control rabbits in vivo 
is phosphorylated to >2 mol phosphate/m01 subunit 
and that epinephrine administration in vivo causes the 
incorporation of >l mol phosphate in addition. 
Glycogen synthase purified here from perfused rat 
skeletal muscle showed the presence of a 40 OOOM, 
protein on SDS-polyacrylamide gel electrophoresis. 
This protein cannot be phosphorylated by CAMP- 
dependent protein kinase, CAMP-independent protein 
kinase or phosphorylase kinase (T. R. Soderling, per- 
sonal communication) and thus may not contain phos- 
phate. Since this 40 000 Mr band was included in the 
measured protein, this means that the phosphate con- 
tent of the 85 OOOM, subunit was probably underesti- 
mated. If this 40 000 M, band is corrected for, the 
basal phosphate content in the control would increase 
to 4 mo1/85 000 g protein, and epinephrine would 
cause the incorporation of 2.5 mol in addition. The 
enzyme purification technique is being modified in an 
attempt to produce an enzyme which shows only one 
band on SDS gel electrophoresis. 
This study does not indicate the site(s) of phos- 
phorylation. However, in [26] the control enzyme was 
phosphorylated mainly in the trypsin-insensitive 
region, consistent with our conclusion [ 151 that phos- 
phorylation was mainly due to the activity of a CAMP- 
independent synthase kinase(s). As would be predicted 
from an increase in the activity of CAMP-dependent 
protein kinase, epinephrine increased the phosphate 
content of the trypsinsensitive region of the enzyme 
[26,27]. Studies are in progress to determine the 
effects of insulin on the phosphorylation state of the 
enzyme in rat hindlimb muscle perfused without and 
with epinephrine. 
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